Mood Disorders News

Migraine has a bidirectional relationship with mental disorders such as anxiety and depression, and one may increase the risk of the other, researchers reported in Cureus.

The American Psychiatric Association said it is pleased that provisions in the Consolidated Appropriations Act of 2023 will promote access to mental health and substance use disorder care, according to a statement on its website.

Vistagen announced it has agreed to acquire Pherin Pharmaceuticals Inc., to bolster its efforts on discovery and development of therapeutics to treat a range of psychiatric and neuropsychiatric conditions.

Resilience and organizational support protected against burnout, while social support and resilience led to better mental health outcomes among health care workers a year after the COVID-19 pandemic.

Factors for risk for rehospitalization for those with psychiatric disorders included suicidal ideation, suicide attempt, previous hospitalization and longer stay in hospital, according to a study published in BMC Psychiatry.

A biotech company based in the U.K. announced that it has initiated a phase 2a study for BPL-003for treatment-resistant depression.

The consumption of walnuts was shown to reduce academic stress and bolster mental health among university students, especially women, researchers reported in Nutrients.

According to a recently released poll, 74% of U.S. workers would rather speak to an app than their own human resources team about their mental health, and 59% would rather speak to an app than their manager.

For adults in Denmark, diagnosis of mental disorders led to a significant impact on the number of working years when compared with the general population, according to a study published in Lancet Psychiatry.

In this video, Michael E. Thase, MD, MS, spoke with Healio about his poster presentation from the 2022 NEI Congress regarding clinical trial results on cariprazine for adjunctive treatment of major depressive disorder.